Cockerell Dermatopathology, Pa

CLIA Laboratory Citation Details

3
Total Citations
22
Total Deficiencyies
8
Unique D-Tags
CMS Certification Number 45D2057348
Address 2110 Research Row, Dallas, TX, 75235
City Dallas
State TX
Zip Code75235
Phone(214) 530-5200

Citation History (3 surveys)

Survey - January 8, 2025

Survey Type: Standard

Survey Event ID: 1PGQ11

Deficiency Tags: D0000 D5781 D6168 D0000 D5781 D6168 D6171 D6171

Summary:

Summary Statement of Deficiencies D0000 The facility was found to be out of compliance with CLIA regulations 42 CFR Part 493. CONDITION LEVEL DEFICIENCIES were found to be out of compliance: 493.1487 Testing Personnel, high complexity D5781

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - January 13, 2023

Survey Type: Standard

Survey Event ID: WDYD11

Deficiency Tags: D0000 D5217 D5411 D0000 D5217 D5411

Summary:

Summary Statement of Deficiencies D0000 Laboratory representatives were present at the entrance conference. The survey process was discussed. An opportunity for questions and comments was given. The exit conference was held with the laboratory representatives. The laboratory was found to be in substantial compliance for the specialties/subspecialties for which it was surveyed. The standard level deficiencies cited were discussed. The process for submitting the corrections was explained. CMS form 2567 will be emailed from the Texas Health and Human Services Commission, Health Facility Compliance Arlington Group. Note: The CMS-2567 (Statement of Deficiencies) is an official, legal document. All information must remain unchanged except for entering the

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - June 3, 2021

Survey Type: Standard

Survey Event ID: OSD311

Deficiency Tags: D0000 D5217 D5413 D5477 D0000 D5217 D5413 D5477

Summary:

Summary Statement of Deficiencies D0000 An entrance conference was held with the laboratory representatives. The survey process was discussed and survey forms were provided. An opportunity for questions and comments was given. Noted deficiencies and plans of correction were discussed with the laboratory representatives at the exit conference. The laboratory representatives were given an opportunity to provide evidence of compliance with the noted deficiencies, and no such evidence was provided prior to survey exit. The facility was found to be in COMPLIANCE with applicable Conditions of Participation in the CLIA program, and recertification is recommended. Note: The CMS-2567 (Statement of Deficiencies) is an official, legal document. All information must remain unchanged except for entering the

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access